beluuga.ai

Overview

Retail Trade

CAWACHI LIMITED

Kawachi Drug operates a chain of large-format drugstores primarily in suburban areas across the Kanto, Tohoku, and neighboring regions of Japan, selling pharmaceuticals, cosmetics, daily necessities, food, and beverages. The company specializes in 'Mega Drugstores' with floor space of 400 to 1,000 tsubo (approx. 1,300–3,300 sqm), featuring single-floor, barrier-free layouts with ample parking tailored to car-dependent communities. In addition to retail, the company actively develops prescription dispensing pharmacies co-located within its stores, supporting Japan's medical separation policy.

Activists: Kaname Capital, L.P. 5.01%

Market Cap

¥91.1B

US$581M

¥62.7B

US$400M

Stock¥4,080▲+1.12%

US$1 = ¥156.80 (2026-10-23)

LTM EV/EBITDA

5.5

LTM EV/EBIT

9.0

LTM PER

28.0

LTM PBR

0.8

Stock vs TOPIX (1Y, base=100)vs TOPIX ▲+15.1%pt

Oct 23, 25 – Oct 23, 26StockTOPIX

1Jun 10, 26Kaname Capital, L.P. filed large shareholding report

2Aug 4, 26Board approved share buyback

MC → EV Bridge

AI Briefing

Generating insights…

Performance & Balance

Revenue 5Y (¥B)

EBITDA 5Y (¥B)

Net Income 5Y (¥B)

Capital Structure

87%

EquityD/E 0.14xDebt

Liquidity vs Debt 5Y (¥B)▲ Net Cash

CashInv. Sec.Debt

Shareholders

Top 10 hold 54.2%

as of 2026-03-15 · Source: Annual Securities Report

Kawachi Scholarship Foundation

11.64%

Shinji KAWACHI

10.92%

Kazuma KAWACHI

10.24%

The Master Trust Bank of Japan, Ltd. (Trust Account)

7.04%

Hiroko KAWACHI

5.96%

Taka KAWACHI

3.17%

CAWACHI LIMITED Employee Stock Ownership Association

1.46%

Custody Bank of Japan, Ltd. (Trust Account)

1.35%

PERSHING-DIV.OF DLJ SECS.CORP. (Standing Proxy: Citibank, N.A., Tokyo Branch)

1.27%

JAPAN ABSOLUTE VALUE FUND (Standing Proxy: Tachibana Securities Co., Ltd.)

1.11%

Management

8 officers

Shinji KAWACHI

Representative Director, President

May 1983 Joined the Company May 1991 Director Oct 1993 Director, General Manager, Human Resources Development Department Jun 1999 Senior Managing Director Mar 2000 Senior Managing Director, General Manager, Business Planning Office Jun 2002 Representative Director, President (current)

1957-03-31

Katsuyuki OKUBO

Director, in charge of Development

Apr 1983 Joined the Company Apr 2005 Deputy General Manager, Merchandise Department Apr 2011 Deputy General Manager, Store Operations Department Sep 2012 General Manager, Store Operations Department Mar 2013 Executive Officer, General Manager, Store Operations Department Jun 2015 Director, General Manager, Sales Division Apr 2019 Director, General Manager, Store Development Department Jan 2022 Representative Director, President, Yokohama Pharmacy Co., Ltd. (current) May 2026 Director, in charge of Development (current)

1964-09-04

Rinji WATANABE

Director

Apr 1990 Joined Nomura Research Institute, Ltd. Nov 1999 Joined Schroder Toshi Investment Management Co., Ltd. (now Schroder Investment Management (Japan) Limited) Mar 2009 Representative Director, President, Lindsay Advisory Co., Ltd. (current) Jun 2016 Director of the Company (current)

1966-11-18

Miho ETO

Director

May 1995 Joined Microsoft Corp. Oct 2015 Head of SnapMart Business, OptIncubate Inc. Aug 2016 Representative Director, SnapMart Inc. Apr 2019 Director, General Manager, Marketing Strategy Department, Tochigi SC Co., Ltd. May 2022 General Manager, Marketing Department, Nankatsu SC Co., Ltd. Jun 2022 Director of the Company (current) Dec 2022 Outside Director, Mynavi Corporation (current) Jan 2026 General Manager, Management Planning Office, Nankatsu SC Co., Ltd. (current) Feb 2026 Representative Director, CoreZone Co., Ltd. (current)

1972-07-24

Yoshio TAMURA

Full-time Audit & Supervisory Board Member

Mar 1975 Joined the Company Mar 2002 General Manager, Tochigi Block Apr 2006 General Manager, Tochigi Area Feb 2011 Left the Company Jun 2013 Full-time Audit & Supervisory Board Member of the Company (current)

1956-10-18

Yuji SAWADA

Audit & Supervisory Board Member

Apr 1996 Registered as Attorney-at-Law Jan 2009 Managing Partner, Utsunomiya Chuo Law Office (current) Jun 2015 Audit & Supervisory Board Member of the Company (current) Apr 2020 President, Tochigi Bar Association

1968-02-03

Toshiyuki OKAYASU

Audit & Supervisory Board Member

May 2006 Registered as Certified Tax Accountant Jul 2006 Head, Toshiyuki Okayasu Certified Tax Accountant Office (current) May 2017 Audit & Supervisory Board Member, Yokohama Pharmacy Co., Ltd. (current) Jun 2024 Audit & Supervisory Board Member of the Company (current)

1976-12-01

Tsuyoshi OTANI

Audit & Supervisory Board Member

Apr 1980 Joined Yamanouchi Pharmaceutical Co., Ltd. (now Astellas Pharma Inc.) Aug 1997 Deputy General Manager, Shakuri Business Division Aug 1997 Director, Shakuri Corporation (U.S. subsidiary) Aug 2001 Deputy General Manager, IR, Public Relations Department Jun 2003 General Manager, European Business, Europe Department Oct 2005 Seconded to European Holding Company (UK), Head of Internal Audit Apr 2009 General Manager, Internal Audit Department Jun 2013 Full-time Audit & Supervisory Board Member, Astellas Pharma Inc. Jun 2016 Outside Audit & Supervisory Board Member, AEON Financial Service Co., Ltd. Feb 2017 Director, Practical Corporate Governance Research Association Feb 2023 Representative Director, Practical Corporate Governance Research Association (current) Jun 2024 Audit & Supervisory Board Member of the Company (current)

1955-07-30

Large Shareholding Reports

Kaname Capital, L.P.

2026-06-10

5.01%

Disclosures

No disclosures

Primary Source Filings

TDnet

2026-07-29

Q1 Earnings Flash

FY ending Mar 2027

CAWACHI LIMITED

Try the full product

CAWACHI LIMITED

Try the full product

More Japanese companies in Retail Trade